Neogen Corp. (NASDAQ:NEOG) VP Edward Bradley sold 21,600 shares of Neogen Corp. stock in a transaction on Tuesday, November 22nd. The stock was sold at an average price of $61.16, for a total transaction of $1,321,056.00. Following the transaction, the vice president now directly owns 144,130 shares of the company’s stock, valued at $8,814,990.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Neogen Corp. (NASDAQ:NEOG) opened at 62.95 on Friday. Neogen Corp. has a 1-year low of $43.79 and a 1-year high of $63.40. The firm has a market cap of $2.37 billion, a P/E ratio of 64.23 and a beta of 1.50. The company has a 50-day moving average price of $55.54 and a 200-day moving average price of $55.01.

Neogen Corp. (NASDAQ:NEOG) last released its quarterly earnings results on Tuesday, September 27th. The company reported $0.26 EPS for the quarter, meeting analysts’ consensus estimates of $0.26. The business earned $83.65 million during the quarter. Neogen Corp. had a return on equity of 9.36% and a net margin of 11.25%. The company’s quarterly revenue was up 11.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.25 earnings per share. On average, equities research analysts forecast that Neogen Corp. will post $1.12 EPS for the current fiscal year.

Insider Buying and Selling by Quarter for Neogen Corp. (NASDAQ:NEOG)

A number of equities research analysts have recently weighed in on NEOG shares. Craig Hallum raised Neogen Corp. from a “hold” rating to a “buy” rating in a report on Tuesday, August 9th. Zacks Investment Research raised Neogen Corp. from a “hold” rating to a “buy” rating and set a $64.00 target price for the company in a report on Tuesday, September 27th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the company’s stock. Neogen Corp. has an average rating of “Hold” and an average target price of $58.25.

A number of large investors have recently added to or reduced their stakes in NEOG. Credit Suisse AG raised its stake in Neogen Corp. by 44.7% in the third quarter. Credit Suisse AG now owns 44,921 shares of the company’s stock worth $2,512,000 after buying an additional 13,874 shares during the last quarter. Bell State Bank & Trust increased its position in shares of Neogen Corp. by 3.7% in the third quarter. Bell State Bank & Trust now owns 4,681 shares of the company’s stock worth $262,000 after buying an additional 165 shares during the period. D. E. Shaw & Co. Inc. acquired a new position in shares of Neogen Corp. during the third quarter worth about $916,000. The Manufacturers Life Insurance Company acquired a new position in shares of Neogen Corp. during the third quarter worth about $1,399,000. Finally, HighTower Advisors LLC acquired a new position in shares of Neogen Corp. during the third quarter worth about $208,000. 86.09% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This news story was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this news story can be read at https://www.thecerbatgem.com/2016/11/25/edward-bradley-sells-21600-shares-of-neogen-corp-neog-stock.html.

Neogen Corp. Company Profile

Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.

5 Day Chart for NASDAQ:NEOG

Receive News & Stock Ratings for Neogen Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen Corp. and related stocks with our FREE daily email newsletter.